Burkitt lymphoma: A successful chemo-sensible malignant process

Cancer Science & Therapy

ISSN: 1948-5956

Open Access

Burkitt lymphoma: A successful chemo-sensible malignant process

Joint Event on 28th International Conference on Cancer Research and Anticancer Therapies & International Conference on Oncogenesis & Oncologic Emergency Medicine & 3rd International Conference on Tumor & Cancer Immunology and I

September 17-18, 2018 | San Diego, USA

Narjiss Akerzoul and Saliha Chbicheb

Mohammed V University Of Rabat, Morocco

Scientific Tracks Abstracts: J Cancer Sci Ther

Abstract :

Burkitt's lymphoma is a rare form of malignant non-Hodgkin lymphoma mature B cells. In Europe and North America, representing about half of non-Hodgkin lymphomas in children and about 2% of those in adults. Indeed, two incidence peaks exist: the first is in childhood/adolescence/early adulthood and the second after 40 years. Male individuals are preferentially affected. Patients infected with the HIV virus and that the antiviral therapy is not optimal are particularly susceptible to developing Burkitt's lymphoma. Two forms exist: one is called "endemic" (subtropical Africa) and linked to the Epstein Barr Virus (EBV). Diagnosis is based on biopsy of a mass or puncture of an effusion or bone marrow revealing the presence of tumor cells. The staging is performed using imaging (mainly ultrasound and scanner). Differential diagnosis includes other forms of child abdominal tumors (such as Wilms' tumor and neuroblastoma. The management should be done in a specialized center in oncology/hematology. The treatment is based on chemotherapy which is some months but intensive. Our clinical observation reports the case of a girl aged 13 who presented with severe oral manifestations of budding Burkitt lymphoma having evolved after 2 years of treatment.

Biography :

Narjiss Akerzoul received her Doctorate of Dental Surgery (DDS) from Mohammed V University of Rabat-Morocco in the year 2011. Later she was working as a General practitioner Dentist in Oral Health Center of Guelmim City, Morocco. Later in 2013, she started her residency program in Oral Surgery and Oral Medicine and OroFacial Pain in the Consultation Center of Dental Treatments of Rabat. Later on, she completed her Diploma in Biostatistics and Research Methodology during 2014-2015. She achieved her Board examination of Oral Surgery and Oral Medicine and OroFacial Pain in July 2017 and became An Oral Surgeon Fellow. She has authored and co-authored many International Publications in the field of Oral Surgery, Oral Medicine and Oral Oncology. She has been an editorial member in Department of Oral and Maxillofacial Surgery of the International Journal of Oral Health and Medical Research (IJOHMR), Reviewer and Editor in OMICS GROUP Biomedical Journals. Her research includes Oral Surgery, Oral & Maxillofacial Surgery, Oral Medicine, Oral Oncology, Head & Neck Oncology, Oral Implantology, Oral Infectious Diseases.



Google Scholar citation report
Citations: 3968

Cancer Science & Therapy received 3968 citations as per Google Scholar report

Cancer Science & Therapy peer review process verified at publons

Indexed In

arrow_upward arrow_upward